Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "NAL"

5533 News Found

Drager launches Atlan A100 anesthesia workstation in India
News | April 12, 2025

Drager launches Atlan A100 anesthesia workstation in India

The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments


FDA approves Opdivo plus Yervoy as treatment metastatic colorectal cancer
Drug Approval | April 12, 2025

FDA approves Opdivo plus Yervoy as treatment metastatic colorectal cancer

The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date


Morepen to add 1,000 medical representatives
News | April 12, 2025

Morepen to add 1,000 medical representatives

The company is targeting a Rs. 1,000 crore finished dosages business within the next five years


Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension
Drug Approval | April 12, 2025

Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension

Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas


Orchid Pharma to settle disputes with DBS Bank
News | April 11, 2025

Orchid Pharma to settle disputes with DBS Bank

The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes


Biocon Biologics announces USFDA approval for Jobevne biosimilar Bevacizumab
Drug Approval | April 11, 2025

Biocon Biologics announces USFDA approval for Jobevne biosimilar Bevacizumab

Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis


Zeon Lifesciences appoints GK Sharma as Group Technical Director
People | April 11, 2025

Zeon Lifesciences appoints GK Sharma as Group Technical Director

Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables


AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
News | April 10, 2025

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025

Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections


Shilpa’s Unit-2 passes second consecutive FDA inspection with no 483s
Drug Approval | April 09, 2025

Shilpa’s Unit-2 passes second consecutive FDA inspection with no 483s

Raichur site is the group’s largest API facility and part of a wider network of seven sites


ZIM Laboratories and Globalpharma collaborate to commercialize oral thin film products in GCC
News | April 09, 2025

ZIM Laboratories and Globalpharma collaborate to commercialize oral thin film products in GCC

This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral